跳至主要内容
临床试验/NCT03896607
NCT03896607终止不适用

Prospective Study: Shear-Wave Elastography of the Liver and the Spleen in Adult Patients With Gaucher's Disease

HaEmek Medical Center, Israel1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2019年3月30日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
18
试验地点
1
主要终点
Shear Wave Elastography of liver to asses liver fibrosis in Gaucher disease patients.

研究概览

简要总结

The investigated cohort will examine liver and spleen fibrosis in patients with Gaucher Disease(GD) by using Shear Wave Elastography- SWE to evaluation fibrosis of the tissue and to check the correlation of fibrosis with the biomarkers of disease severity.

详细描述

To assess liver and spleen stiffness measurement using Shear Wave Elastography-SWE and evaluate liver and spleen fibrosis in patients with Gaucher Disease. To compare the elastography with the biomarkers that taken at the GD haematology clinic and to check the correlation with severity of liver and spleen fibrosis.

SWE is a safe with diagnostic accuracy regarding the liver (& Spleen) fibrosis. Estimating spleen fibrosis is an innovative approach in liver disease and Gaucher.

The evaluation of fibrosis with this relatively new and safe method could avoid complications and invasive procedure in GD patients .

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with Gaucher disease over the age of 18 years.
  • Patients able to sign informed consent form.
  • Women are not pregnant.
  • Patients who read and understood the contents of the consent form and gave their written consent to participate in the study.

排除标准

  • Participants under the age of
  • Pregnant women.
  • Participants are unable to sign an informed consent form.
  • Participants with known liver disease not associated with Gaucher disease such as liver cirrhosis, patients with HBV, HBC or liver cirrhosis.

结局指标

主要结局

Shear Wave Elastography of liver to asses liver fibrosis in Gaucher disease patients.

时间窗: 0-2 hours

Shear wave elastography(SWE),an ultrasound imaging technique that can produce 2D and 3D images and quantified measurements of tissue stiffness noninvasively. SWE obtained from the right liver lobe for staging liver fibrosis according to Metavir Fibrosis Score with sensitivity86%-98% and specificity 90%-93%. SWE well corelated with Metavir Fibrosis Score which is system used to assess the extent of inflammation and fibrosis by histopathological evaluation in a liver biopsy. The biomarkers of disease severity will be correlated to METAVIR score. METAVIR score(F0-F4) ,Fibrosis Level measured by KPa(kiloPascal) using SWE. F0 = Below 5 KPa, No fibrosis. F1=5.0-7.1 KPa, Mild Fibrosis. F2=7.1-8.7 KPa, Significant Fibrosis. F3=8.7-10.4 KPa, Sever Fibrosis. F4=10.4-19 KPa ,Cirrhosis. SWE can differentiate patients with no or minimal (F0 and F1) fibrosis from those with severe fibrosis or cirrhosis (F3 and F4) with no need for biopsy unless there are other factors that need to be considered.

次要结局

  • Shear Wave Elastography of spleen to asses spleen fibrosis in Gaucher disease patients.(0-2 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ziv Neeman

Head of Radiology department

HaEmek Medical Center, Israel

研究点 (1)

Loading locations...

相似试验